ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
66.899,61
-0,27%
Brent Oil
83,76
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Soleno Therapeutics Inc (SLNO)

  7. Soleno Therapeutics Inc (SLNO) Notícias

SLNO

Soleno Therapeutics (SLNO)

Soleno Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SLNO
DataHoraFonteTítuloCódigoCompanhia
15/05/202409:00GlobeNewswire Inc.Soleno Therapeutics Stands with the Prader-Willi Syndrome CommunityNASDAQ:SLNOSoleno Therapeutics Inc
09/05/202417:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SLNOSoleno Therapeutics Inc
09/05/202417:05GlobeNewswire Inc.Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:SLNOSoleno Therapeutics Inc
07/05/202418:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SLNOSoleno Therapeutics Inc
06/05/202417:58Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SLNOSoleno Therapeutics Inc
02/05/202423:32GlobeNewswire Inc.Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common StockNASDAQ:SLNOSoleno Therapeutics Inc
02/05/202417:01GlobeNewswire Inc.Soleno Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:SLNOSoleno Therapeutics Inc
30/04/202409:00GlobeNewswire Inc.Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi SyndromeNASDAQ:SLNOSoleno Therapeutics Inc
29/04/202409:00GlobeNewswire Inc.Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)NASDAQ:SLNOSoleno Therapeutics Inc
19/04/202417:05GlobeNewswire Inc.Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SLNOSoleno Therapeutics Inc
06/03/202418:05GlobeNewswire Inc.Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:SLNOSoleno Therapeutics Inc
22/02/202410:00GlobeNewswire Inc.Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:SLNOSoleno Therapeutics Inc
31/01/202418:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SLNOSoleno Therapeutics Inc
29/01/202419:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SLNOSoleno Therapeutics Inc
24/01/202410:00GlobeNewswire Inc.Soleno Therapeutics Strengthens Leadership Team with Key AppointmentsNASDAQ:SLNOSoleno Therapeutics Inc
02/01/202418:06Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:SLNOSoleno Therapeutics Inc
14/12/202319:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SLNOSoleno Therapeutics Inc
07/11/202310:00GlobeNewswire Inc.Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:SLNOSoleno Therapeutics Inc
06/11/202310:00GlobeNewswire Inc.Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Long-Term Open-Label Study of DCCR in Prader-Willi SyndromeNASDAQ:SLNOSoleno Therapeutics Inc
01/11/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SLNOSoleno Therapeutics Inc
20/10/202317:32Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SLNOSoleno Therapeutics Inc
16/10/202317:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SLNOSoleno Therapeutics Inc
12/10/202317:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SLNOSoleno Therapeutics Inc
04/10/202319:16GlobeNewswire Inc.Correcting & Replacing -- Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research SymposiumNASDAQ:SLNOSoleno Therapeutics Inc
04/10/202317:05GlobeNewswire Inc.Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research SymposiumNASDAQ:SLNOSoleno Therapeutics Inc
04/10/202311:36Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SLNOSoleno Therapeutics Inc
02/10/202317:05GlobeNewswire Inc.Soleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:SLNOSoleno Therapeutics Inc
28/09/202309:30GlobeNewswire Inc.Soleno Therapeutics Announces Pricing of Approximately $120 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and/or Pre-Funded WarrantsNASDAQ:SLNOSoleno Therapeutics Inc
28/09/202308:02Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:SLNOSoleno Therapeutics Inc
27/09/202322:32Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:SLNOSoleno Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SLNO

Seu Histórico Recente

NASDAQ
INDV
Indivior
MRTX
XSGETH
Tent [SnowGem]
COIN
ETFETH
ETF The Token
BITMOT
876517
Intsanpaolo Tf 2,1% Nv30...
NYSE
SPNT
SiriusPoint
COIN
BCHOLDGBP
NASDAQ
CTRN
Citi Trends
COIN
PERLGBP
BIT
UB48JF
Unicredit Bank
COIN
PROPELETH
PayRue Propel
COIN
SPLGBP
NASDAQ
TRKAW
Troika Media
BIT
UC610G
Unicredit Bank
BIT
P1NYU2
BNP Paribas Issuance
GATE
SBUSDT
DragonSB (Wormhole)
BIT
UC5GU5
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados